From: Clinical foot measurements as a proxy for plantar pressure testing in people with diabetes
 | Total population (n = 136) |
---|---|
Age (years) | 68.4 (11.5) |
Male (n (%)) | 71 (52.2%) |
BMI (kg/m2) | 32.7 (6.3) |
Type 2 diabetes (n %) | 123 (90.4%) |
Duration of diabetes (years) | 14.6 (11.1) |
HbA1c (n = 104) | 7.2 (1.2) |
Insulin therapy alone or combination (n (%)) | 35 (25.7%) |
Oral hypoglycaemics alone or in combination with insulin (n (%)) | 100 (73.5%) |
Diet-controlled diabetes (n (%)) | 18 (13.2%) |
Hypertension (n (%)) | 98 (72.1%) |
Cardiovascular disease (n (%)) | 36 (26.5%) |
History of DFU (n (%)) | 5 (3.7%) |
Monofilament neuropathy (LOPS) (n (%)) | 43 (31.6%) |
LOPS with foot deformity (n (%)) | 16 (11.8%) |
Lunge equinus (n (%)) | 42 (31%) |
Hallux limitus (n (%)) | 38 (28%) |
Hallux abductus valgus score > 2 (n (%)) | 27 (20%) |
Toe deformities > = 1 (n (%)) | 29 (21%) |
Barefoot forefoot peak pressure (kPa) | 687.6 (291.5) |
In-shoe forefoot peak pressure (kPa) | 234.1 (52.1) |